Impact of in-hospital major bleeding on outcomes in acute coronary syndromes

Current Opinion in Cardiology

Volumn 27, Issue 6, 2012, Pages 669-674

  Choi, Sharon S ^a   Sergie, Ziad ^a   Mehran, Roxana ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

acute coronary syndrome; antithrombin; bivalirudin; major bleeding; percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; CLOPIDOGREL; DIGOXIN;

ACUTE CORONARY SYNDROME; ANEMIA; BLEEDING; BLOOD CONSERVATION; BLOOD TRANSFUSION; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY FAILURE; COMORBIDITY; FOLLOW UP; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMATOMA; HOSPITAL DISCHARGE; HUMAN; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TACHYCARDIA; THROMBOCYTE DYSFUNCTION;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, BALLOON, CORONARY; ANTITHROMBINS; HEMORRHAGE; HIRUDINS; HOSPITALIZATION; HUMANS; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84868303070     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3283589572     Document Type: Review

References (26)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics - 2012 update: A report from the American Heart Association. Circulation 2012; 125:e2-e220.
2. Anderson JL, Adams CD, Antman EM, et al. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123:e426-e579.
3. Subherwal S, Peterson ED, Dai D, et al. Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: A report from the National Cardiovascular Data CathPCI Registry. J Am Coll Cardiol 2012; 59:1861-1869.
4. Stone GW, Witzenbichler B, Guagliumi G, et al. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): Final 3-year results from a multicentre, randomised controlled trial. Lancet 2011; 377:2193-2204. These results showed that a mortality benefit exists over the short term and long term. 5. Suh JW,Mehran R, Claessen BE, et al. Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol 2011; 58:1750-1756.
5. Lopes RD, Subherwal S, Holmes DN, et al. The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction. Eur Heart J 2012; 33:2044-2053.
6. Sergie Z, Mehran R, Stone GW. What is the optimal antithrombotic strategy in primary percutaneous coronary intervention? Curr Opin Cardiol 2012; 27:361-367.
7. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008; 358:2218-2230.
8. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123:2736-2747.
9. Jolly SS, Yusuf S, Cairns J, et al. Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes. Am Heart J 2011; 161:254-260.
10. White HD, Aylward PE, Gallo R, et al. Hematomas of at least 5cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial. Am Heart J 2010; 159:110-116.
11. Valgimigli M, Saia F, Guastaroba P, et al. Transradial versus transfemoral intervention for acute myocardial infarction: A propensity score-adjusted and -matched analysis from the REAL (REgistro regionale AngiopLastiche dell'-Emilia-Romagna) multicenter registry. JACCCardiovasc Intervent 2012; 5:23-35.
12. Verheugt FW, Steinhubl SR, Hamon M, et al. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. JACC Cardiovasc Intervent 2011; 4:191-197.
13. Joyal D, Bertrand OF, Rinfret S, et al. Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention. Am J Cardiol 2012; 109:813-818.
14. Mehta RH, Parsons L, Peterson ED. Comparison of bleeding and in-hospital mortality in Asian-Americans versus Caucasian-Americans with ST-elevation myocardial infarction receiving reperfusion therapy. Am J Cardiol 2012; 109:925-931.
15. Bangalore S, Cohen DJ, Kleinman NS, et al. Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: Results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Intervent 2011; 4:463-473.
16. Spencer FA, Moscucci M, Granger CB, et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 2007; 116:2793-2801.
17. De Berardis G, Lucisano G, D'Ettorre A, et al. Association of aspirin use with major bleeding in patients with and without diabetes. JAMA 2012; 307:2286-2294.
18. Hogman CF, Knutson F, Loof H, et al. Improved maintenance of 2,3 diphosphoglycerate (DPG) and adenosine triphosphate (ATP) in red blood cells (RBCs) stored in a modified additive solution. Transfusion 2002; 42:824-829.
19. Wang TY, Xiao L, Alexander KP, et al. Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding. Circulation 2008; 118:2139-2145.
20. (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
21. Mehran R, Pocock S, Nikolsky E, et al. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Intervent 2011; 4:654-664.
22. Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: The CRUSADE (Can apid Risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) bleeding score. Circulation 2009; 119:1873-1882.
23. Pattakos G, Koch CG, Brizzio ME, et al. Outcome of patients who refuse transfusion after cardiac surgery: A natural experiment with severe blood conservation outcome of patients who refuse transfusion. Arch Intern Med 2012; 172: 1154-1160.
24. Marso SP, Amin AP, House JA, et al. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA 2010; 303:2156-2164.
25. Dodson JA, Wang Y, Chaudhry SI, et al. Bleeding-avoidance strategies and outcomes in patients >/80 Years of age with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the NCDR CathPCI Registry). Am J Cardiol 2012; 110:1-6.
26. Kadakia MB,Desai NR, Alexander KP, et al. Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: A report from the NCDR ACTION Registry Y GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network RegistryYGet With the Guidelines). JACC Cardiovasc Intervent 2010; 3:1166-1177.